Home
PHVS

PHVS

Pharvaris N.V.

as of 12-16-2025 2:31pm EST

$24.50

+$0.60

+2.51%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Chart Type:

Time Range:

Founded:	2015	Country:	Switzerland
Employees:	N/A	City:	N/A
Market Cap:	1.7B	IPO Year:	2021
Target Price:	$39.44	AVG Volume (30 days):	563.8K
Analyst Decision:	Buy	Number of Analysts:	9
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-3.40	EPS Growth:	N/A
52 Week Low/High:	$11.51 - $29.80	Next Earning Date:	11-12-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered PHVS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 20 hours ago

AI Recommendation

hold

Model Accuracy: 70.47%

70.47%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full PHVS Forecast & Prediction with Hourly Data

Compare PHVS vs Leading Stocks

See how PHVS stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free PHVS Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "PHVS Pharvaris N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.